 |
 |
Featured Service |
|
| |
|
|
| |
Vaccine trials – a growing specialization at Radiant ResearchRadiant Research, a comprehensive clinical research company that provides Phase I-IV clinical drug development and conduct services to the biopharmaceutical industry, has developed significant and growing expertise in vaccine development. |
|
| |
|
|
|
| |
 |
More Info |
|
|
|
| Upcoming Events |
|
Radiant Research, Inc. Prepares for Upcoming H1N1 Vaccine Trials Places Focus on Subject Identification and Operational Planning
“Our research sites are ideal for this type of clinical trial,” said Julie McHugh, Vice President of Late Phase Clinical Research, Radiant Research, Inc. “We have conducted over 200 vaccine trials and enrolled thousands of subjects into these trials in the past five years. We know how to enroll these trials quickly and efficiently, and we enforce the standards that ensure quality data collection.”
“We have over a million subjects in our database and they are both familiar with the research process and very interested in this type of trial,” said Michael Kritschgau, Vice President of Radiant Recruitment. “We are currently making contact with these potential subjects so we can be ready to enroll once the manufacturers are ready to move to the clinical trials stage. We anticipate that companies producing the vaccine will soon be reaching out to various research facilities; we will be ready when we get that call.”
|
|
|